Clive S. Zent, M.D.

Cancer

Clinical Interests

Hematologic Oncology; Lymphoma, Chronic Lymphocytic Leukemia

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-1042

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Research Labs

Visit Lab Website

Locations

Wilmot Cancer Institute
601 Elmwood Ave
Rochester, NY 14642-0001

Oncology: (585) 275-5823

Faculty Appointments

Professor - Department of Medicine , Hematology/Oncology (SMD)
Professor - Cancer Center - Joint

Biography

I chose this specialty because I have always had an interest in diseases of the blood. My patients can be confident knowing I provide optimal individual patient care based on precision diagnosis and targeted therapy. Although I treat many types of blood diseases, my area of expertise is chronic lymphocytic leukemia.

Conditions I Treat:

- Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL)
- Hairy cell leukemia
- Prolymphocytic leukemia
- Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)
- Large granular lymphocytic leukemia

Professional Background

Dr. Clive Zent is a highly experienced hematologist and internationally recognized researcher and expert in the care of patients with chronic lymphocytic leukemia (CLL) and related lymphoid malignancies. While training in Hematology at the University of Chicago, Dr. Zent studied the molecular genetics of hematological malignancies in the laboratory of Dr. Janet Rowley. His clinical and research interest in CLL started as an attending physician at the Central Arkansas Veterans Healthcare System and continued when he joined the staff of the Mayo Clinic in Rochester MN in 2003. In 2013 he was appointed to the faculty of the Wilmot Cancer Center at the University of Rochester Medical Center as Professor of Medicine and director of the Chronic Lymphocytic Leukemia program.

Research

Dr. Zent's research has improved our understanding of the therapeutic monoclonal antibodies used to treat CLL, use of molecular prognostic markers in the management of CLL, diagnosis of CLL and related diseases, and evaluation and management of autoimmune cytopenias and second malignancies complicating CLL. His goal as a clinician, researcher and teacher is to continue to improve treatment and outcome for patients with CLL.

Credentials

Specialties

Hematology - American Board of Internal Medicine
Internal Medicine - American Board of Internal Medicine

Education

1983
MBBCh | University of the Witwatersrand

1987-1991
MMed | University of Cape Town
Internal Medicine

Post-doctoral Training & Residency

7/1/1996 - 6/30/1997
Residency in Internal Medicine at University of Arkansas College of Medicine

7/1/1993 - 6/30/1996
Fellowship in Hematology at University of Chicago Medical Center

2/1/1987 - 1/31/1991
Residency in Internal Medicine at Groote Schuur Hospital - University of Cape Town

1/1/1984 - 12/31/1984
Internship in Internal Medicine at University of Witwatersrand

VIEW ALL

Awards

2008
Teacher of the Year in Hematology
Sponsor: Mayo Fellows Association, College of Medicine
Location: Mayo Clinic

1995
Kaminer Fellowship (Travel Award)
Sponsor: University of Chicago
Location: Chicago, IL

1983
Degree with Distinction
Sponsor: University of the Witwatersrand
Location: South Africa

VIEW ALL

Publications

Journal Articles

10/2018
VanDerMeid KR, Elliott MR, Baran AM, Barr PM, Chu CC, Zent CS. "Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies." Cancer immunology research.. 2018 Oct 0; 6(10):1150-1160. Epub 2018 Aug 08.

9/13/2018
Musilova K, Devan J, Cerna K, Seda V, Pavlasova G, Sharma S, Oppelt J, Pytlik R, Prochazka V, Prouzova Z, Trbusek M, Zlamalikova L, Liskova K, Kruzova L, Jarosova M, Mareckova A, Kornauth C, Simonitsch-Klupp I, Schiefer AI, Merkel O, Mocikova H, Burda P, Machova Polakova K, Kren L, Mayer J, Zent CS, Trneny M, Evans AG, Janikova A, Mraz M. "downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels." Blood.. 2018 Sep 13; Epub 2018 Sep 13.

9/2018
Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C. "Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States." Haematologica.. 2018 Sep 0; 103(9):1511-1517. Epub 2018 Jun 07.

Books & Chapters

2016
Chapter Title: Chronic lymphocytic leukemia/small lymphocytic lymphoma.
Book Title: ASH-SAP American Society of Hematology Self-Assessment Program
Author List: Zent CS, Call TG
Edited By: Steensma DP, Cuker A, Kempton CL
Published By: American Society of Hematology2016

2010
Chapter Title: Chronic lymphocytic leukemia causing multiple mononeuropathies
Book Title: Companion to Peripheral Neuropathy: Illustrated Cases and New Developments
Author List: Mauermann ML, Zent CS, Low PA
Edited By: Dyck PJ, et.al.
Published By: Saunders/Elsevier2010 in Philadelphia

2010
Chapter Title: Disorders of the Blood
Book Title: Textbook of Medicine
Author List: Zent C and Polliack A
Edited By: Warrel D, Cox T, Firth J
Published By: Oxford2010

VIEW ALL PUBLICATIONS